Abstract
Henoch-Schönlein purpura nephritis (HSPN) is the most prevalent vasculitis in childhood worldwide. Although the etiology of HSPN is not yet fully elucidated, it is believed to be closely related with infections and genetic predispositions. In this study, a cohort of children from southeast China, including 108 healthy controls and 184 patients were involved in. We scanned the promoter region and the whole gene for genetic variations. A C/T transition located in the promoter region of MMP-9 gene, C-1562T was identified. Subjects were genotyped by using SNaPshot sequencing and the frequencies of CC, CT and TT genotypes were 43, 33 and 24% in patients and 53, 37 and 10% in healthy controls. Allele distribution was found to be in Hardy–Weinberg equilibrium (P = 0.17). Association analysis revealed that the polymorphism was significantly related with HSPN risk (P < 0.05) and T allele was shown to be a risk factor (P = 0.003, odds ratio (OR) 1.63, 95% confidence interval (CI) 1.13–2.34). Additionally, we measured the serum MMP-9 concentration and quantified the mRNA expression. Results showed that an elevated protein level was observed in patients compared with controls in both ELISA (P = 0.0029, 136.5 μg/L vs. 103.9 μg/L) and Western blot assays. Furthermore, we also detected 1.93-fold increase in the mRNA transcription in patients carrying homozygous TT genotype, indicating enhanced promoter activity caused by the polymorphism. Based on the incidence risk, a cut-off value of serum MMP-9 served as HSPN diagnosis was suggested at 155 μg/L. Conclusively, our findings suggested that MMP-9 polymorphism was significantly associated with HSPN susceptibility, and C-1562T T allele contributed to HSPN development.
Similar content being viewed by others
References
Besbas N, Saatci U, Ruacan (1997) The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 26:456–460
Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579–1585
Duvuru G, Stone JH (2013) Henoch-Schönlein purpura In Current diagnosis and treatment, 3rd edn. McGraw-Hill, New York, pp 183–204
Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. The Lancet 360:1197–1202
Hu CT, Yan JW, Chen F, Zhang QX, Wang HD, Yin CY, Fan HT, Hu LL, Shen CM, Meng HT et al (2016) Genetic analysis of 15 mtDNA SNP loci in Chinese Yi ethnic group using SNaPshot minisequencing. Gene 576:105–108
Lau KK, Suzuki H, Novak J, Wyatt RJ (2010) Pathogenesis of Henoch-Scho ̈nlein purpura nephritis. Pediatr Nephrol 25:179–184
Li SY, Huang PH, Yang AH, Tarng DC, Yang WC, Lin CC, Chen JW, Schmid-Schönbein G, Lin SJ (2014) Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte fuctions and dedifferentiation. Kidney Int 86:358–369
Liu RR, Wang MY, Lai YR (2010) Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China. J Hematol Oncol 3:29
Marson BP, Lacchini R, Belo V, Mattos SG, da Costa BP, Poli-de-Figueiredo CE, Tanus-Santos JE (2012) Fuctional matrix metalloproteinase-9 genetic variants modify the effects of hemodialysis on circulation MMP-9 levels. Clin chim Acta 414:46–451
Parks WC, Wilson CL, Lo ́pez-Boado YS (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4:617–629
Pohl M (2015) Henoch-Schönlein purpura nephritis. Pediatr Nephrol 30:245–252
Qin YH, Zhou TB, Lei FY, Huang WF, Zhao YJ, Lin FQ, Su LN (2011) Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schönlein purpra in children. Nephrology 16:93–99
Rostoker G (2001) Schönlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 15:99–138
Saulsbury FT (2002) Epidermiology of Henoch-Schönlein Perpura. Cleve Clin J Med 69:187–189
Shin J, Song K, Kim H, Cho NH, Kim J, Kim HS, Lee JS (2011) The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura. Br J Dermatol 164:1348–1355
Singh K, Agrawal NK, Gupta SK, Singh K (2013) A functional single nucleotide polymorphism −1562C > T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Int J Low Extrem Wounds 12:199–204
Ting TV (2014) Diagnosis and management of cutaneous vasculitis in children. Pediatr Clin North Am 61:321–346
Yukihiko K, Atsushi O, Shinichiro O, Suzuki Y, Suyama K, Suzuki J, Hosoya M (2013) Henoch-Schönlein perpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci 59:15–26
Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A et al (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–1794
Zhao H, Dong Y, Tian X, Tan TK, Liu Z, Zhao Y, Zhang Y, Harris DCh, Zheng G (2013) Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World. J Nephrol 2:84–89
Zhong Y, Zhang X, Cai X, Wang K, Chen Y, Deng Y (2014) Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. PLoS One 9:e85690
Zhou TB, Qin YH (2012) The potential mechanism for the different expressions of gelatinases induced by all-trans retinoic acid in different cells. J Recept Signal Transduct Res 32:129–133
Zhou T, Yin S (2013) Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schönlein purpura in children. Ren fail 35:425–429
Acknowledgements
This study was supported by the grant from Medical Scientific Research Foundation of Wuxi (YGM1122).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declares that they have no conflict of interest.
Ethical approval
The study was approved by the Ethics Committee of our hospital and written informed consents were obtained from all the enrolled subjects and their parent before the study entry.
Rights and permissions
About this article
Cite this article
Xu, J., Zhao, L., Zhou, H. et al. Association of MMP-9 C-1562T polymorphism with risk of Henoch-Schönlein purpura nephritis in children of southeast China. Genes Genom 39, 379–385 (2017). https://doi.org/10.1007/s13258-016-0502-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-016-0502-7